Tetrahydrofuran → N-[2-chloro-5-({2-[(cyclopropylcarbonyl)amino][1,2,4]triazolo[1,5-a]pyridin-6-yl}oxy)phenyl]-2,4-dimethyl-1,3-oxazole-5-carboxamide

HRID 1874504

반응식

HRID 1874504 반응식
[CH3:1][C:2]1[O:3][C:4]([C:8]([OH:10])=O)=[C:5]([CH3:7])[N:6]=1.O1CCCC1.S(Cl)(Cl)=O.[NH2:20][C:21]1[CH:22]=[C:23]([CH:40]=[CH:41][C:42]=1[Cl:43])[O:24][C:25]1[CH:26]=[CH:27][C:28]2[N:29]([N:31]=[C:32]([NH:34][C:35]([CH:37]3[CH2:39][CH2:38]3)=[O:36])[N:33]=2)[CH:30]=1>CN(C)C=O.CN(C)C(=O)C>[Cl:43][C:42]1[CH:41]=[CH:40][C:23]([O:24][C:25]2[CH:26]=[CH:27][C:28]3[N:29]([N:31]=[C:32]([NH:34][C:35]([CH:37]4[CH2:39][CH2:38]4)=[O:36])[N:33]=3)[CH:30]=2)=[CH:22][C:21]=1[NH:20][C:8]([C:4]1[O:3][C:2]([CH3:1])=[N:6][C:5]=1[CH3:7])=[O:10]

참가 물질

7

실험 절차

In the same manner as in Example 55 and using 2,4-dimethyl-1,3-oxazole-5-carboxylic acid (51.8 mg, 0.367 mmol), tetrahydrofuran (5 mL), thionyl chloride (63.3 μL, 0.730 mmol), N,N-dimethylformamide (2 drops), N-[6-(3-amino-4-chlorophenoxy)[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide (114 mg, 0.332 mmol) and N,N-dimethylacetamide (6 mL) as starting materials, the title compound (98.4 mg, 63%) was obtained as a pale-brown solid.

출처 및 근거

ORD 기록
ord-162b1d3cb7ba4b3fa719e657b1ccd5ea
출처 데이터셋
uspto-grants-2012_11
특허 번호
US08304557B2

연결된 노트

불러오는 중…